Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in asthma control
Change in rescue medication usage
Secondary outcome measures
Acceptability of BreatheSmart system
Change in controller medication adherence
Trial Design
1Treatment groups
Experimental Treatment
Group I: BreatheSmartExperimental Treatment1 Intervention
104 subjects will be provided with the BreatheSmart platform, which consists of:
HeroTracker sensor that monitors real-time asthma medication adherence
Mobile spirometer that offer remote clinical-grade lung function monitoring
BreatheSmart mobile application that provides patients with real-time alerts, environmental information (weather, pollution, etc.), and the ability to complete questionnaires / surveys.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BreatheSmart
2017
N/A
~210
Find a Location
Who is running the clinical trial?
CoheroHealthLead Sponsor
4 Previous Clinical Trials
132 Total Patients Enrolled
4 Trials studying Asthma
132 Patients Enrolled for Asthma
Anne Tam, MPHStudy DirectorCohero Health, Inc.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger